TPA
Trivium Point Advisory’s DexCom DXCM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $286K | Sell |
3,276
-179
| -5% | -$15.6K | 0.03% | 292 |
|
|
2025
Q1 | $236K | Buy |
3,455
+200
| +6% | +$13.7K | 0.03% | 313 |
|
|
2024
Q4 | $253K | Sell |
3,255
-37
| -1% | -$2.88K | 0.03% | 306 |
|
|
2024
Q3 | $239K | Sell |
3,292
-496
| -13% | -$36K | 0.03% | 306 |
|
|
2024
Q2 | $429K | Sell |
3,788
-71
| -2% | -$8.05K | 0.06% | 220 |
|
|
2024
Q1 | $535K | Buy |
3,859
+63
| +2% | +$8.74K | 0.12% | 153 |
|
|
2023
Q4 | $471K | Buy |
3,796
+53
| +1% | +$6.58K | 0.11% | 147 |
|
|
2023
Q3 | $340K | Buy |
3,743
+272
| +8% | +$24.7K | 0.09% | 159 |
|
|
2023
Q2 | $446K | Sell |
3,471
-12
| -0.3% | -$1.54K | 0.12% | 157 |
|
|
2023
Q1 | $405K | Hold |
3,483
| – | – | 0.11% | 157 |
|
|
2022
Q4 | $403K | Sell |
3,483
-448
| -11% | -$51.9K | 0.12% | 150 |
|
|
2022
Q3 | $374K | Sell |
3,931
-78
| -2% | -$7.42K | 0.12% | 153 |
|
|
2022
Q2 | $328K | Buy |
4,009
+2,997
| +296% | +$245K | 0.1% | 165 |
|
|
2022
Q1 | $516K | Buy |
1,012
+80
| +9% | +$40.8K | 0.11% | 170 |
|
|
2021
Q4 | $500K | Sell |
932
-6
| -0.6% | -$3.22K | 0.1% | 164 |
|
|
2021
Q3 | $506K | Buy |
938
+85
| +10% | +$45.9K | 0.12% | 152 |
|
|
2021
Q2 | $364K | Buy |
853
+99
| +13% | +$42.2K | 0.09% | 169 |
|
|
2021
Q1 | $271K | Buy |
754
+152
| +25% | +$54.6K | 0.07% | 176 |
|
|
2020
Q4 | $233K | Buy |
+602
| New | +$233K | 0.07% | 172 |
|